KR100722578B1 - 비오틴-결합 수용체 분자 - Google Patents

비오틴-결합 수용체 분자 Download PDF

Info

Publication number
KR100722578B1
KR100722578B1 KR1020007009270A KR20007009270A KR100722578B1 KR 100722578 B1 KR100722578 B1 KR 100722578B1 KR 1020007009270 A KR1020007009270 A KR 1020007009270A KR 20007009270 A KR20007009270 A KR 20007009270A KR 100722578 B1 KR100722578 B1 KR 100722578B1
Authority
KR
South Korea
Prior art keywords
thr
leu
glu
ser
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007009270A
Other languages
English (en)
Korean (ko)
Other versions
KR20010085196A (ko
Inventor
셉포 일라-헐투알라
마르쿠 쿨로마아
파울리이나 레흐톨라이넨
발푸 마르조마키
카리 아이렌네
Original Assignee
아크 테라퓨틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803757.5A external-priority patent/GB9803757D0/en
Priority claimed from GBGB9813653.4A external-priority patent/GB9813653D0/en
Application filed by 아크 테라퓨틱스 리미티드 filed Critical 아크 테라퓨틱스 리미티드
Publication of KR20010085196A publication Critical patent/KR20010085196A/ko
Application granted granted Critical
Publication of KR100722578B1 publication Critical patent/KR100722578B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020007009270A 1998-02-23 1999-02-23 비오틴-결합 수용체 분자 Expired - Fee Related KR100722578B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9803757.5 1998-02-23
GBGB9803757.5A GB9803757D0 (en) 1998-02-23 1998-02-23 Fusion proteins
GB9813653.4 1998-06-24
GBGB9813653.4A GB9813653D0 (en) 1998-06-24 1998-06-24 Fusion proteins

Publications (2)

Publication Number Publication Date
KR20010085196A KR20010085196A (ko) 2001-09-07
KR100722578B1 true KR100722578B1 (ko) 2007-05-28

Family

ID=26313170

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007009270A Expired - Fee Related KR100722578B1 (ko) 1998-02-23 1999-02-23 비오틴-결합 수용체 분자

Country Status (16)

Country Link
US (1) US7208291B2 (https=)
EP (1) EP1056850B1 (https=)
JP (1) JP2002504328A (https=)
KR (1) KR100722578B1 (https=)
CN (1) CN1195852C (https=)
AT (1) ATE274058T1 (https=)
AU (1) AU750444B2 (https=)
CA (1) CA2319039A1 (https=)
DE (1) DE69919515T2 (https=)
DK (1) DK1056850T3 (https=)
ES (1) ES2226340T3 (https=)
HU (1) HUP0101614A3 (https=)
NO (1) NO328139B1 (https=)
PL (1) PL195990B1 (https=)
PT (1) PT1056850E (https=)
WO (1) WO1999042577A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209294A1 (en) * 2002-09-02 2004-10-21 National Food Research Institute Method to produce a receptor chip using biotinylated protein
US9623117B2 (en) * 2011-04-04 2017-04-18 Wisconsin Alumni Research Foundation Method for selective targeting and entry of bacterial toxins to cells
CN113354744A (zh) * 2013-12-20 2021-09-07 弗雷德哈钦森癌症研究中心 带标签的嵌合效应分子及其受体
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005026A1 (en) * 1986-02-24 1987-08-27 The Trustees Of Columbia University In The City Of Dna encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
WO1997019957A1 (en) * 1995-11-30 1997-06-05 New York University High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5457035A (en) 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5846537A (en) 1995-06-07 1998-12-08 University Of Rochester Modified avidin and streptavidin and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005026A1 (en) * 1986-02-24 1987-08-27 The Trustees Of Columbia University In The City Of Dna encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
WO1997019957A1 (en) * 1995-11-30 1997-06-05 New York University High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FASEB J., vol.9(6), pp.A1395, 1995.4.24. *

Also Published As

Publication number Publication date
DE69919515D1 (de) 2004-09-23
JP2002504328A (ja) 2002-02-12
US20040185059A1 (en) 2004-09-23
HUP0101614A2 (hu) 2001-09-28
WO1999042577A3 (en) 1999-10-21
CA2319039A1 (en) 1999-08-26
PL343079A1 (en) 2001-07-30
DK1056850T3 (da) 2004-11-29
PT1056850E (pt) 2004-12-31
NO328139B1 (no) 2009-12-14
DE69919515T2 (de) 2005-04-07
KR20010085196A (ko) 2001-09-07
PL195990B1 (pl) 2007-11-30
ES2226340T3 (es) 2005-03-16
AU2631299A (en) 1999-09-06
EP1056850A2 (en) 2000-12-06
US7208291B2 (en) 2007-04-24
AU750444B2 (en) 2002-07-18
NO20004195L (no) 2000-08-22
EP1056850B1 (en) 2004-08-18
CN1195852C (zh) 2005-04-06
ATE274058T1 (de) 2004-09-15
CN1291230A (zh) 2001-04-11
HUP0101614A3 (en) 2006-04-28
WO1999042577A2 (en) 1999-08-26
NO20004195D0 (no) 2000-08-22

Similar Documents

Publication Publication Date Title
EP1991560B1 (en) Peptide having cell membrane penetrating activity
US7638281B2 (en) Polypeptide, cDNA encoding the same and use of them
US7423139B2 (en) High level expression of recombinant human erythropoietin having a modified 5′-UTR
US20200246420A1 (en) pHLIP® peptide-mediated epitope tethering at cell surfaces
JP6574175B2 (ja) 細胞透過性ペプチド、及びそれを含むコンジュゲート
KR100629185B1 (ko) 인간 리조포스파티드산 수용체 물질 및 그 용도
WO2008100122A1 (en) Oligomerizaed protein transduction domains, a method for preparing the same and an intracellular transduction method using the same
KR100722578B1 (ko) 비오틴-결합 수용체 분자
US5925548A (en) Modified receptors that continuously signal
EP1163334A1 (en) Polynucleotide and deduced amino acid sequences from stromal cells
EP1363942A2 (de) Polypeptide eines hdm2-protein spezifischen murinen alpha/beta t-zell rezeptors, diese kodierende nukleinsüren und deren verwendung
JP2002504328A5 (https=)
MXPA00007931A (en) Biotin-binding receptor molecules
AU2018455720B2 (en) Mutated human 2IG-B7-H3 protein coding gene, recombinant vector, host cell containing same, pharmaceutical composition and application thereof
JP2003526323A (ja) Kdel受容体インヒビター
US8101736B2 (en) Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same
ES2264564T3 (es) Factor de crecimiento htter36.
TW200902545A (en) Compositions and methods of using CRMP-1 and its fragments for treating cancer
CA2410525A1 (en) Fas ligand-fused proteins
AU773085B2 (en) Transfer compounds, the production and the use thereof
JPWO2000001405A1 (ja) 軟骨細胞の分化促進剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P20-X000 Errors in documents filed by the applicant or ip right owner corrected

St.27 status event code: A-2-2-P10-P20-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100522

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100522